| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |